Effects of Resistance Training in Body Composition and Body Image Perception of Women Throughout the Menstrual Cycle

September 27, 2021 updated by: Southern Illinois University Edwardsville
The objective of this research study is two-fold, 1) to determine if body composition and body image perception are affected through the different phases of the menstrual cycle, and 2) if an acute session of resistance training can have different effects depending on the menstrual cycle phase.

Study Overview

Detailed Description

The purpose of the research is to establish whether body composition and body image perception are affected throughout the different phases of the menstrual cycle and if the perception can be modified through resistance training. To the best of our knowledge, only one study has analyzed the effects of the menstrual cycle on body image perception. However, research analyzing the effects of the menstrual cycle on both body image perception and, body composition is lacking. Furthermore, research in the effects of resistance training on menstrual cycle-related changes on both perceived and measured body composition are inexistent. Findings from this study have the potential to increase the knowledge about resistance training's effects in modulating body image perception throughout the menstrual cycle. Further understanding of these responses may set the groundwork to develop exercise intervention programs to reduce the risk of developing more serious mental conditions linked to unhealthy body image perception.

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Edwardsville, Illinois, United States, 62026
        • Southern Illinois University Edwardsville

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female
  • Sedentary or Active
  • 18.5-34.9 kg/m2 BMI
  • Normal menstrual cycle defined as 28 to 30 days and a duration of 3 to 7 days
  • Age range is 18-45 years old
  • The inclusion of other participants may alter the results as an increase in body fat has been linked to known changes in different hormonal levels and those changes might influence substrate utilization
  • Changes in the hormonal status of pre-menopausal women may appear without symptoms
  • Younger females also display variations in their hormones since they are going through the process of development

Exclusion Criteria:

  • Previous physiological and mental health history
  • Pregnant females
  • Males
  • Irregular menstrual cycle, menstrual dysfunction or unusual sex hormone levels
  • Musculoskeletal injuries
  • Contraceptives, a medication that alters hormonal or cardio-respiratory responses
  • Pre-menopausal symptoms
  • On moderate to high-intensity exercise regime more than 2 days/week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early Follicular Phase (EFP)
The group will engage in the Resistance Training intervention on the fourth day of their menstrual cycle, which will correlate with the middle of the early follicular phase (EFP).
This intervention will take place on day 4 of the participants' menstrual cycle. This will correspond to the mid-point of the early follicular phase (EFP).
Experimental: Late Follicular Phase (LFP)
The group will engage in the Resistance Training intervention on the eleventh day of their menstrual cycle, which will correlate with the middle of the late follicular phase (LFP).
The intervention will take place on day 8 of the participants' menstrual cycle. This will correspond to the mid-point of the late follicular phase (LFP).
Experimental: Early Luteal Phase (ELP)
The group will engage in the Resistance Training intervention on the eighteenth of their menstrual cycle, which will correlate with the middle of the early luteal phase (ELP).
The intervention will take place on day 18 of the participants' menstrual cycle. This will correspond to the mid-point of the early luteal phase (ELP).
Experimental: Late Luteal Phase (LLP)
The group will engage in the Resistance Training intervention on the twenty-fifth day of their menstrual cycle, which will correlate with the middle of the late luteal phase (LLP).
The intervention will take place on day 25 of the participants' menstrual cycle. This will correspond to the mid-point of the late luteal phase (LLP).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Image Perception through questionnaire
Time Frame: Through study completion: an average of 1 month
Participants will be distributed the Multidimensional Body-Self Relations Questionnaire-Appearance Scale (MBSRQ-AS) to measure their body image perceptions.
Through study completion: an average of 1 month
Body Image Perception through drawing scale
Time Frame: Through study completion: an average of 1 month
Participants will be distributed the Contour Drawing Rating Scale to measure their body image perception.
Through study completion: an average of 1 month
Barriers to Weight Control
Time Frame: Through study completion: an average of 1 month
Participants will be distributed the Survey of Barriers to Weight Control to measure their body image perception.
Through study completion: an average of 1 month
Fat Mass in Kilograms
Time Frame: Through study completion: an average of 1 month
We will measure fat mass using the Dual-Energy Xray Absorptiometry (DXA)
Through study completion: an average of 1 month
Lean Body Mass in Kilograms
Time Frame: Through study completion: an average of 1 month
We will measure lean body mass using the Dual-Energy Xray Absorptiometry (DXA)
Through study completion: an average of 1 month
Relative Body Fat
Time Frame: Through study completion: an average of 1 month
We will measure relative body fat (percentage) using the Dual-Energy Xray Absorptiometry (DXA)
Through study completion: an average of 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bench Press One Repetition Maximum
Time Frame: At baseline: 1 assessment point prior randomization
Participants muscular strength will be assessed by a one-repetition (1RM) on bench press
At baseline: 1 assessment point prior randomization
Leg Press One Repetition Maximum
Time Frame: At baseline: 1 assessment point prior randomization
Participants lower body muscular strength will be assessed by a one-repetition (1RM) on leg press
At baseline: 1 assessment point prior randomization
Dietary habits
Time Frame: Before each exercise session: 1 assessment point on each menstrual cycle phase
The participants diet will be recorded using the ASA-24h recall
Before each exercise session: 1 assessment point on each menstrual cycle phase
Estrogen (Estradiol) levels
Time Frame: Before each exercise session: 1 assessment point on each menstrual cycle phase
Blood will be drawn from the participants for assessment of the estrogen hormone
Before each exercise session: 1 assessment point on each menstrual cycle phase
Progesterone levels
Time Frame: Before each exercise session: 1 assessment point on each menstrual cycle phase
Blood will be drawn from the participants for assessment of the progesterone hormone
Before each exercise session: 1 assessment point on each menstrual cycle phase

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria Fernandez del Valle, PhD, Southern Illinois University Edwardsville

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2019

Primary Completion (Actual)

March 16, 2020

Study Completion (Actual)

March 16, 2020

Study Registration Dates

First Submitted

May 21, 2019

First Submitted That Met QC Criteria

July 29, 2019

First Posted (Actual)

July 30, 2019

Study Record Updates

Last Update Posted (Actual)

October 4, 2021

Last Update Submitted That Met QC Criteria

September 27, 2021

Last Verified

July 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Body Image Disturbance

Clinical Trials on EFP

3
Subscribe